Drug Abuse Testing Market Statistics by Size, Demand, Share, Renowned Players, Key Regions, Segments, Top Trends and Forecast to 2027
The players in the market are adopting various inorganic and organic developments for individual growth, and thus, the growth of the market is highly dependent on them. The vital players in the drug abuse testing market focus on various growth strategies to strengthen their presence and accordingly hold major market share across the global market. Some of the notable players in the global drug abuse testing market include, Redwood Toxicology Laboratory (Abbott), F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., OraSure Technologies, Inc., UCP Biosciences, MEDACX Ltd., Beckman Coulter, Inc. (Danaher), Alcolizer Pty Ltd., Wondfo, DRÄGERWERK AG & CO. KGAA, American Screening Corporation, Inc, Mercedes Medical, Alfa Scientific Designs, Inc., Express Diagnostics Int'l, Inc., Omega Laboratories, Inc. and Laboratorio Sodré.
Request Sample Copy at https://www.theinsightpartners.com/sample/TIPHE100001303/?utm_source=OpenPR&utm_medium=Sumaiya
Global Analysis and Forecasts by Product, Sample Type and End User.’ The global drug abuse testing market is expected to reach US$ 9,393.17 Mn in 2027 from US$ 5,783.71 Mn in 2018. The market is estimated to grow with a CAGR of 5.7% from 2019-2027. The report highlights the trends prevalent in the global drug abuse testing market and the factors driving the market along with those that act as deterrents to its growth.
Global drug abuse testing market, based on the end user, was segmented as, hospitals, diagnostic laboratories and forensic laboratories. In 2018, hospitals held the largest share of the market, by end user. In addition, the segment is also anticipated to grow at a significant rate during the forecast period. The advanced healthcare facilities in hospital settings and continuous availability of services for acute and complex conditions factors are anticipated to lead to the growth of the segment during the forecast period.
The market for drug abuse testing is expected to grow, owing to factors such as increasing consumption of illicit drugs and laws and regulations related to drug abuse. In addition, growing adoption of LIMS in cannabis testing laboratories is likely to have a positive impact on the growth of the market in the coming years.
The major market players within recent years have been observed to invest a substantial amount towards the development of new products. This implies a bright picture of the type of strategies majorly incorporated by the market players to retain their positions as well as to generate increased growth revenue in the drug abuse testing market. The global leaders in the market have been majorly adopting strategies such as mergers & acquisitions and agreements as key strategies to improve its product offerings in order to build up customer-centric benefits to its end users and enhance its geographic diversification.
In order to strengthen their customer base, global leaders have adopted strategies such as mergers & acquisitions and agreements with other companies operating in the market. For instance, in October, 2017, Abbott announced that in a filing with the US Securities And Exchange Commission, it has completed its acquisition of Alere, concluding a deal first announced in February 2016. Redwood Toxicology Laboratory, which was initially a part of Alere was also acquired by Abbott as a part of this strategic acquisition.
Apart from inorganic growth strategies, the companies have also adopted organic growth strategies such as, product launch & development and expansion during recent years. For instance, Beckman Coulter Diagnostics announced the addition of 6-Acetylmorphine (6-AM) and Buprenorphine (BUP) assays to its broad menu of drugs-of-abuse tests that meet the demands of onsite testing laboratories.
Asia Pacific (APAC)
Middle East & Africa (MEA)
South and Central America
Buy this Report now at https://www.theinsightpartners.com/buy/TIPHE100001303/?utm_source=OpenPR&utm_medium=Sumaiya
About Us – The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
Contact us –
Email Id: firstname.lastname@example.org
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Drug Abuse Testing Market Statistics by Size, Demand, Share, Renowned Players, Key Regions, Segments, Top Trends and Forecast to 2027 here
News-ID: 1837335 • Views: 328
More Releases from The Insight Partners
Exterior Doors Market 2027 Growing with Top Key Leaders Andersen Corporation, As …
The Global Exterior Doors Market Analysis to 2027 is a specialized and in-depth study of the Exterior doors industry with a special focus on the global market trend analysis. The report aims to provide an overview exterior doors market with detailed market segmentation as door type, material, mechanism, end-user, and geography. The global exterior doors market is expected to witness high growth during the forecast period. The report provides key
Latest Research on Vodka Market with Top Key Players: BELVEDERE VODKA, Bacardi, …
The research report provides a big picture on "Vodka market" 2027, on a global basis, offering a forecast and statistic in terms of revenue during the forecast period. This report covers detailed segmentation, complete R & D history, and explanatory analysis including the latest news. Furthermore, the study explains the future opportunities and a sketch of key players involved in the Vodka hike in terms of revenue. Vodka market - key
Pulmonary Devices Market: Analysis 2020-2027 by Types, Applications and 20 Key P …
According to our latest study on “Pulmonary Devices Market Forecast to 2027– COVID-19 Impact and Global Analysis– by type, application, and end user,”. The growth of the pulmonary devices market is attributed to factors such asrising number of COVID-19 cases worldwide and increasing prevalence of respiratory diseases. However, the unfavorable reimbursement scenario associated with the respiratory devices restrain the growth of the market. Koninklijke Philips N.V, Caire Inc. (Chart Industries), Inogen
RegTech Market To Observe Exponential Growth By 2020-2027| Abside Smart Financia …
The regtech refers to regulatory technology which utilizes information technology for enhancing the regulatory processes within the financial industry. A rise in digital products and services has led to increased incidents of data breaches, money laundering, cyber-attacks and similar fraudulent activities. Regtech helps in minimizing these activities in the financial institutions by making use of big data and machine learning technology. The report provides study at and regional level to provide
More Releases for Drug
Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning